Printer Friendly

Corrigendum to "Potential Extensions of the US FRAX Algorithm".

In the article titled "Potential Extensions of the US FRAX Algorithm" [1], the authors wish to correct the affiliation of John A. Kanis. This should have been listed as Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield S10 2RX, UK. In the section on FRAX[R] calculations, "Fracture probabilities were calculated by the World Health Organization Collaborating Centre for Metabolic Bone Diseases" should read "Fracture probabilities were calculated by the Centre for Metabolic Bone Diseases."

In the Introduction, FRAX is described as "the World Health Organization's fracture risk assessment tool". The Metabolic Bone Diseases Unit at the University of Sheffield that developed FRAX was a WHO Collaborating Centre from 1991 to 2010 and FRAX is based on data generated from that centre. However, the WHO and the University of Sheffield say FRAX was not developed or endorsed by the WHO [2]; Professor Kanis disagrees with that position.


[1] L. Joseph Melton III, E. J. Atkinson, S. J. Achenbach et al., "Potential Extensions of the US FRAX Algorithm," Journal of Osteoporosis, vol. 2012, Article ID 528790, 8 pages, 2012.

[2] N. Ford, S. L. Norris, and S. R. Hill, "ClarifyingWHO's position on the FRAX[R] tool for fracture prediction," Bulletin of the World Health Organization, vol. 94, no. 12, article 862, 2016.

Journal of Osteoporosis

Correspondence should be addressed to Journal of Osteoporosis;

Received 28 September 2017; Accepted 17 October 2017; Published 2 April 2018

COPYRIGHT 2018 COPYRIGHT 2010 SAGE-Hindawi Access to Research
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Corrigendum
Publication:Journal of Osteoporosis
Article Type:Correction notice
Date:Jan 1, 2018
Previous Article:Study of Endothelio- and Osteoprotective Effects of Combination of Rosuvastatin with L-Norvaline in Experiment.
Next Article:Nutritional Aspects of Bone Health and Fracture Healing.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters